Trial Profile
Preference for Fluzone vaccine [influenza virus vaccine] Administered Intradermally Versus Intramuscularly in Healthy Adult Subjects 18-49 Years of Age.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2014
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi
- 13 Jan 2010 Actual number of patients (110) added as reported by ClinicalTrials.gov record.
- 13 Jan 2010 Actual end date (1 Jun 2008) added as reported by ClinicalTrials.gov record.
- 13 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.